|
NMT2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.208090E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.337000E-01 |
| Normal-vs-Stage2 |
1.402560E-01 |
| Normal-vs-Stage3 |
2.407600E-04 |
| Normal-vs-Stage4 |
9.785900E-04 |
| Stage1-vs-Stage2 |
1.645030E-01 |
| Stage1-vs-Stage3 |
3.603300E-04 |
| Stage1-vs-Stage4 |
7.974900E-04 |
| Stage2-vs-Stage3 |
2.598800E-01 |
| Stage2-vs-Stage4 |
2.261200E-01 |
| Stage3-vs-Stage4 |
7.570000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.166100E-02 |
| Normal-vs-AfricanAmerican |
7.99840000000884E-05 |
| Normal-vs-Asian |
1.489360E-01 |
| Caucasian-vs-AfricanAmerican |
2.741200E-03 |
| Caucasian-vs-Asian |
6.341600E-01 |
| AfricanAmerican-vs-Asian |
5.334000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.900100E-02 |
| Normal-vs-Female |
4.235400E-03 |
| Male-vs-Female |
2.255000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.426600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.043800E-02 |
| Normal-vs-Age(61-80Yrs) |
1.762150E-02 |
| Normal-vs-Age(81-100Yrs) |
4.301400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.208400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.058000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.434400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.414400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.607000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.541200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.719800E-02 |
| Normal-vs-Grade 2 |
6.499400E-01 |
| Normal-vs-Grade 3 |
1.227980E-02 |
| Normal-vs-Grade 4 |
2.47879999999423E-05 |
| Grade 1-vs-Grade 2 |
1.581360E-01 |
| Grade 1-vs-Grade 3 |
3.912200E-02 |
| Grade 1-vs-Grade 4 |
3.255100E-03 |
| Grade 2-vs-Grade 3 |
2.536100E-02 |
| Grade 2-vs-Grade 4 |
5.95749999999784E-05 |
| Grade 3-vs-Grade 4 |
4.939000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.009500E-02 |
| Normal-vs-ccB subtype |
1.36520000004747E-06 |
| ccA subtype-vs-ccB subtype |
8.99191832104407E-12 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.219500E-02 |
| Normal-vs-N1 |
5.280200E-02 |
| N0-vs-N1 |
2.314600E-01 |
|
|
